Massive intoxication with rivaroxaban, phenprocoumon, and diclofenac

نویسندگان

  • Hella Pfeiffer
  • Larissa Herbst
  • Bernd Schwarze
  • Reinhold Eckstein
  • Volker Weisbach
چکیده

RATIONALE Oral anticoagulants and painkillers, some with an additional effect on the coagulation system, are widely used and are therefore prone to abuse and (intentional) overdose. We report the case of a patient with a massive mixed anticoagulant intoxication. PATIENT CONCERNS The patient had ingested 1960 mg rivaroxaban, 31.5 mg phenprocoumon, 1425 mg diclofenac, and 21,000 mg metamizole in suicidal intention. DIAGNOSES Massive mixed anticoagulant overdose. INTERVENTIONS The patient was closely monitored. The phenprocoumon overdose was treated by the administration of vitamin K and PCC. OUTCOMES Despite the massive inhibition of the coagulation system, the patient did not experience bleeding apart from a slight gross hematuria. LESSONS Despite the ingestion of a massive amount of rivaroxaban, the plasma levels were not as high as feared, due to the ceiling effect of rivaroxaban absorption. Elimination occurred according to the half-life of rivaroxaban and was not unduly prolonged by the ingested quantity.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Safety of continuous periprocedural rivaroxaban for patients undergoing left atrial catheter ablation procedures.

BACKGROUND This study aimed to evaluate the safety of continuous periprocedural rivaroxaban administration during left atrial radiofrequency ablation (RFA) in comparison with uninterrupted oral vitamin K antagonist administration. Data about the use of rivaroxaban in the setting of left atrial RFA procedures are lacking. METHODS AND RESULTS The study cohort included 544 patients (mean age, 63...

متن کامل

Recurrent cerebral venous sinus thrombosis in a patient with increased factor VIII activity, increased lipoprotein (a) level and leukocytosis: a case report.

In this paper, we describe the case of recurrent cerebral venous sinus thrombosis in a patient with increased factor VIII activity, lipoprotein (a) level, and leukocytosis. In addition, we discuss the diagnosis of increased factor VIII activity in patients with cerebral venous thrombosis. With regard to therapy, studies need to be done to establish the duration of therapy with phenprocoumon and...

متن کامل

Clinical and pharmacological properties of new oral anticoagulants for the prevention of cerebral thromboembolism: Factor Xa and thrombin inhibitors

Vitamin K antagonists, such as warfarin and phenprocoumon, are the first-line oral anticoagulants for primary and secondary prevention of cerebral embolism in patients with atrial fibrillation. Although vitamin K antagonists can significantly decrease the risk of stroke, their use is limited by several important drawbacks, such as a narrow therapeutic window, the risk of intracranial and gastro...

متن کامل

What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?

For over half a century oral anticoagulation in atrial fibrillation (AF) was limited to the use of vitamin K antagonists (VKA). Although millions of patients have benefited from drugs like warfarin and phenprocoumon, they come with a large list of disadvantages/problems that result in substantial mortality/morbidity as well as underutilisation of anticoagulation (1). With the aim to avoid these...

متن کامل

Novel factor xa inhibitor for the treatment of cerebral venous and sinus thrombosis: first experience in 7 patients.

BACKGROUND AND PURPOSE Thrombosis of cerebral veins and sinus (cerebral venous thrombosis) is a rare stroke pathogenesis. Pharmaceutical treatment is restricted to heparin and oral anticoagulation with vitamin K antagonists (VKAs). METHODS Between January 2012 and December 2013, we recorded data from our patients with cerebral venous thrombosis. The modified Rankin scale was used to assess cl...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 95  شماره 

صفحات  -

تاریخ انتشار 2016